Novo Nordisk introduces Wegovy for easier obesity care

Novo Nordisk has launched the drug "Wegovy," which facilitates the treatment of obesity, boosting the company's growth alongside its diabetes and cardiovascular medications, and contributing to increased sales of the drug despite competition, as liver medications enter development phases.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل